Level Biotechnology Inc.(TW:3118)
NT$30.15-0.45 (-1.47%)
TW:3118
Level Biotechnology Inc. Revenue
NT$30.15
At close:-0.45 (-1.47%)
Level Biotechnology Inc. (3118) Revenue
Level Biotechnology Inc. Revenue
Level Biotechnology Inc. had a revenue of 162.35M in the quarter ending Jun 30, 2026, with 2.20%. This bring the company's revenue in the last twelve months to 709.37M, Decreased 1.28%. In the fiscal year ending Dec 31, 2025, Level Biotechnology Inc. had annual revenue of 736.59M with 0.72% growth.
- Revenue (ttm)
- 709.37M
- Revenue Growth
- -3.54%
- P/S Ratio
- 1.35
- Revenue/Employee
- TWD 5,754,633
- Employees
- 128
- Market Cap
- TWD 993.06M
Revenue Chart
Level Biotechnology Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 736.59M | 5.25M | 0.72% |
| Dec 31, 2024 | 731.35M | 70.74M | 10.71% |
| Dec 31, 2023 | 660.61M | 67.60M | 11.40% |
| Dec 31, 2022 | 593.01M | -84.27M | -12.44% |
| Dec 31, 2021 | 677.28M | 4.79M | 0.71% |
| Dec 31, 2020 | 672.49M | 33.59M | 5.26% |
| Dec 31, 2019 | 638.90M | 9.87M | 1.57% |
| Dec 31, 2018 | 629.03M | 51.40M | 8.90% |
| Dec 31, 2017 | 577.63M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.